Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Key Movement
    • Novo Nordisk names...

    Novo Nordisk names Vikrant Shrotriya as Managing Director for India business

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2020-01-03T14:21:00+05:30  |  Updated On 3 Jan 2020 2:21 PM IST

    Vikrant Shrotriya was recently working in the GCC (Gulf Cooperation Council) countries wherein he was Vice-President for company's GCC business and Corporate Vice President for Saudi Arabia, Novo Nordisk added.


    New Delhi: Global healthcare firm Novo Nordisk on Thursday said it has appointed Vikrant Shrotriya as Managing Director and Corporate Vice President for India business.


    He returns to India after 13 years with an overall career spanning over 20 years in the healthcare industry in India and internationally, Novo Nordisk said in a statement.


    Vikrant was recently working in the GCC (Gulf Cooperation Council) countries wherein he was Vice-President for company's GCC business and Corporate Vice President for Saudi Arabia, it added.


    Read Also: Novo Nordisk wins USFDA nod for oral diabetes drug Rybelsus


    "India is an important market for us, and our focus is on enhancing healthcare through awareness and education. We will continue to work on improving access to quality care by working closely with the relevant stakeholders," Shrotriya said.


    Novo Nordisk insulins have been in presence in India since 1935 and the Indian affiliate was operationalised in 1994.


    Read Also: Novo Nordisk Tresiba shows lower risk of hypo in adults with Type 2 Diabetes

    GCCGlobal healthcareinsulinsNovo Nordisknovo nordisk mdpharmapharma companypharma newsVikrant Shrotriya
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok